The Nasdaq Biotechnology index has fallen 18.7
percent over the last seven sessions as investors took flight
after Hillary Clinton, front-runner to be the Democratic nominee
in next year's U.S. presidential election, vowed on Sept. 21 to
take steps to curb high drug prices. Since its July 20 high, the